FY22 was something of an annus horribilis for Abingdon due to factors largely outside of its control. As the pandemic has subsided, legacy issues have been resolved and management has cleared the decks for a reset of activities, focussing on a range of Contract Development and Manufacturing opportunities. The settlement with the DHSC has been resolved and £6.4m in cash received post-period end. Management therefore expects there to be no current funding requirement as it moves towards cashflow b ....

24 Nov 2022
FY22 results disappointing – outlook offers promise

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
FY22 results disappointing – outlook offers promise
Abingdon Health PLC (ABDX:LON) | 6.1 0 0.0% | Mkt Cap: 11.8m
- Published:
24 Nov 2022 -
Author:
Chris Glasper -
Pages:
3 -
FY22 was something of an annus horribilis for Abingdon due to factors largely outside of its control. As the pandemic has subsided, legacy issues have been resolved and management has cleared the decks for a reset of activities, focussing on a range of Contract Development and Manufacturing opportunities. The settlement with the DHSC has been resolved and £6.4m in cash received post-period end. Management therefore expects there to be no current funding requirement as it moves towards cashflow b ....